George Bosl

George Bosl (born 1948) is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015.[1][2][3][4] In 2019, he was named Memorial Sloan Kettering's first ombudsperson.[5]

Biography

Bosl earned his bachelor's degree at John Carroll University, in Cleveland, Ohio, and his M.D. at Creighton University School of Medicine in Omaha, Nebraska.[6] He trained in internal medicine at The New York Hospital and worked at Memorial Sloan Kettering Cancer Center as chief medical resident. He completed a fellowship in medical oncology at the University of Minnesota and then returned to Sloan Kettering to join the faculty in 1979.[7] At Memorial Sloan Kettering Cancer Center he has been director of the Oncology/Hematology training program, chief of the Genitourinary Oncology Service, head of the Division of Solid Tumor Oncology, and associate physician-in-chief before becoming chair of the Department of Medicine on February 1, 1997.[6][8][9]

He also heads the Joachim Silbermann Family Program on Aging and Cancer and has received grants from the National Institute of Health to study the sharp increase of older adults developing this disease.[10][11]

Academic work

Bosl is a specialist in the treatment of genitourinary tumors particularly in testicular cancer. He is known for targeting a marker chromosome for Germ cell tumors.[12][13] His studies investigate molecular targets of drug resistance in patients and developing dose-intensive chemotherapy and new chemotherapeutic agents, evaluating new combinations for patients with relapsing or resistant disease.[14] Some of his research is also centered on new therapies for head and neck cancers.[15][16][17] Bosl received many awards and honors, including the Patrick M. Byrne Chair in Clinical Oncology at MSKCC in 1995, the 2005 MSKCC Excellence in Medicine Award, the 2007 American Society of Clinical Oncology Statesman Award, the 2015 American Society of Clinical Oncology Distinguished Achievement Award, and the Mastership designation from the American College of Physicians in 2016.[18][19][20]

References

  1. ^ "Cancer Care Doctor: George J. Bosl, M.D." Memorial Sloan-Kettering Cancer Center. Archived from the original on December 8, 2011. Retrieved February 18, 2013.
  2. ^ Feldman, Darren R.; Bosl, George J. (September 2007). "Nature Clinical Practice Oncology About the authors". Nature Clinical Practice Oncology. 4 (9). Macmillan Publishers Limited: 508–509. doi:10.1038/ncponc0904.(2007) Vo. 4, No. 9, Pg. 508-509
  3. ^ "Weill Cornell Medical College Faculty George J. Bosl, M.D., Professor of Medicine". Weill Cornell Medical College. Retrieved February 19, 2013.
  4. ^ Printz, Carrie (February 2021). "First person profile: George J. Bosl, MD: Former long-term chair of Memorial Sloan Kettering Cancer Center's Department of Medicine reflects on his multifaceted career". Cancer. 127 (3): 331–332. doi:10.1002/cncr.33428. PMID 33434337. S2CID 231588615.
  5. ^ "Respected Physician and Researcher George J. Bosl Named Memorial Sloan Kettering's First Ombudsperson, a Confidential Resource for Staff | Memorial Sloan Kettering Cancer Center". www.mskcc.org. 5 July 2019.
  6. ^ a b "OncologySTAT Advisory Board". Elsevier. Retrieved February 18, 2013.
  7. ^ "U.S. News Top Doctor". U.S. News & World Report. Retrieved February 19, 2013.
  8. ^ "Creighton Medical School Taps Bosl for 2006 Alumni Award". Creighton University. Archived from the original on May 28, 2010. Retrieved September 15, 2006.
  9. ^ Feldman, Darren R.; Bosl, George J. (2007). "Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials". Nature Clinical Practice Oncology. 4 (9): 508–509. doi:10.1038/ncponc0904. PMID 17637730.
  10. ^ Memorial Sloan-Kettering Cancer Center Joachim Silbermann Family Extends Support for Program in Aging & Cancer Archived 2013-03-08 at the Wayback Machine Retrieved on February 14, 2013.
  11. ^ "Development of An Aging and Cancer Program at MSKCC". enGrant Scientific. 2003–2009. No. 5P20CA103694-05.
  12. ^ Bosl, G.J.; Dmitrovsky, E.; Reuter, V.E.; Samaniego, F.; Rodroguez, E.; Geller, N.L.; Chaganti, R.S.K. (December 20, 1989). "Isochromosome of Chromosome 12: Clinically Useful Marker for Male Germ Cell Tumor". Journal of the National Cancer Institute. 81 (24): 1874–1878. doi:10.1093/jnci/81.24.1874. PMID 2556586.
  13. ^ "2006 Alumni Merit Award Recipient". Creighton University. September 15, 2006. Archived from the original on May 28, 2010. Retrieved February 27, 2013.
  14. ^ Ed Edelson"Repeat, High-Dose Chemo Can Cure Testicular". The Washington Post. July 25, 2007.
  15. ^ Pfister, D.G., Harrison, L.B., Strong, EW., Shah, J.P., Spiro, R.W., Kraus, D.H., Armstrong, J.G., Zelefsky, M.J., Fass, D.E., Weiss, M.H., Wang, R.C., Schantz, S.P. and Bosl, G.J., Organ-Function preservation in Advanced Oropharynx Cancer: Results with Induction Chemotherapy and Radiation, Journal of Clinical Oncology, Vol. 13, No. 3, March, 1995: Pg. 671-680
  16. ^ Elisabeth Rosenthal, "The Cancer War: A Major Advance", "The New York Times", October 8, 1989
  17. ^ "Testicular Cancer seen as 'Stalking Horse' for Other Cancers". Journal of the National Cancer Institute. 91 (21): 1801–1803. 3 November 1999. doi:10.1093/jnci/91.21.1801.
  18. ^ New ASCO Statesman Award Honors Meritorious Service and Contributions of Society Members Past and Present[permanent dead link‍] American Society of Clinical Oncology, Retrieved on February 26, 2013
  19. ^ 2006-2007 Annual Report, American Society of Clinical Oncology Archived 2009-09-20 at the Wayback Machine Section 5, Pp. 37, Retrieved on February 26, 2013
  20. ^ Printz, Carrie (February 2021). "First person profile: George J. Bosl, MD: Former long-term chair of Memorial Sloan Kettering Cancer Center's Department of Medicine reflects on his multifaceted career". Cancer. 127 (3): 331–332. doi:10.1002/cncr.33428. PMID 33434337. S2CID 231588615.